CME vs Moody's
Moody's is the larger business, with $7.72bn of revenue in fiscal 2025 against $6.52bn for CME (1.2 times as much). Moody's grew faster (8.9% against 6.4%). CME kept more of each dollar of sales as profit: a net margin of 62.5% against 31.9%.
| Latest fiscal year | CMECME, 2025 | Moody'sMCO, 2025 |
|---|---|---|
| Revenue | $6.52bn | $7.72bn |
| Revenue growth | 6.4% | 8.9% |
| Net income | $4.07bn | $2.46bn |
| Operating margin | 64.9% | — |
| Net margin | 62.5% | 31.9% |
| Return on equity | 14.8% | 64.5% |
| Free cash flow | $4.19bn | $2.58bn |
| Cash | $4.42bn | $2.38bn |
| Total debt | $4.17bn | $6.99bn |
| Debt to equity | 14.5% | — |
| Dividend per share | — | $3.76 |
| Dividend yield | 3.7% | 0.8% |
| Share buybacks | — | $1.61bn |
| Employees | 3,875 | — |
| Market value | $109.07bn | $87.02bn |
| Price vs our value range | Within our value range | Above our value range |
| Moat score | 66 (Moderate) | 90 (Strong) |
| Insider trades, 12 months | 7 buys, 21 sales | 0 buys, 37 sales |